Home > Riviste > Minerva Gastroenterology > Fascicoli precedenti > Articles online first > Minerva Gastroenterology 2021 Dec 21

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Gastroenterology 2021 Dec 21

DOI: 10.23736/S2724-5985.21.02982-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Evaluation of MACK-3 parameters, metabolic and fibrotic characteristics of non-alcoholic fatty liver disease patients with hypertension

Oleg BABAK 1, Kateryna LAPSHYNA 1 , Konstantyn PROSOLENKO 1, Arkadiy CHERNYAK 2, Olena GOPTSIY 1

1 Kharkiv National Medical University, Kharkiv, Ukraine; 2 Government Institution L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine (GI L.T.Mala NIT NAMSU), Kharkiv, Ukraine


PDF


BACKGROUND: Non-alcoholic steatohepatitis (NASH) is an inflammatory subtype of non-alcoholic fatty liver disease (NAFLD) and recent non-invasive test, MACK-3, demonstrated good diagnostic characteristics for fibrosis in a number of studies. The aim of our study was to assess the liver state using the non-invasive MACK-3 test, and its link with liver fibrosis stage, inflammatory activity, steatosis and metabolic markers in NAFLD patients with hypertension (HT).
METHODS: Thirty adult NAFLD patients with HT, aged 30 to 60 years (mean age (46.36 ± 5.1) years) were included in our study. The control group consisted of 20 healthy volunteers. In addition to basic laboratory tests and ultrasonographic examination, validated non-invasive fibrosis test were performed. MACK-3 was calculated using the online calculator with the following variables: fasting glucose, fasting insulin, aspartate aminotransferase (AST) and cytokeratin 18 (CK18).
RESULTS: All NAFLD patients with HT were characterized with increased liver enzymatic activity, lipid profile, increased levels of insulin and HOMAIR (˂ 0.001). MACK-3 parameters were positively correlated with thymol test - direct link - r = 0.45 (p <0.013), with aspartataminotransferase (AST) r = 0.38 (p <0.03) and alanineaminotransferase (ALT) - r = 0.38 (p<0.03), with the stage of Fibrotest activity r = 0.25 (p <0.018) and steatosis r = 0.76 (p <0.001).
CONCLUSIONS: MACK-3 parameters associations with hepatic enzymatic activity, steatosis and activity stage suggest this test as a promising for screening use in such patients and requires further studies.


KEY WORDS: Non-alcoholic fatty liver disease (NAFLD); Non-alcoholic steatohepatitis (NASH); fibrosis; MACK-3

inizio pagina